Malla SB, Fisher D, Domingo E, Blake A, et al. In-depth clinical and biological exploration of DNA Damage Immune Response (DDIR) as a biomarker for oxaliplatin use in colorectal cancer. Clin Cancer Res 2020 Oct 7. pii: 1078-0432.CCR-20-3237.
PMID: 33028592